![Richard Dugan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Dugan
Director/Board Member at
VANDA PHARMACEUTICALS INC.
Net worth: 1 M $ as of 31/05/2026
Profile
Richard W.
Dugan is Lead Independent Director at Vanda Pharmaceuticals, Inc. since 2022.
Formerly, Mr. Dugan was Director at Middlebrook Pharmaceuticals, Inc. from 2003 to 2010, Director at Critical Therapeutics, Inc. from 2004 to 2008, Director at Antisoma, Inc., and Senior Partner at Ernst & Young LLP from 2001 to 2002.
Mr. Dugan completed undergraduate studies at The Pennsylvania State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/06/2026 | 177,454 ( 0.3% ) | 1 M $ | 31/05/2026 |
Richard Dugan active positions
| Companies | Position | Start |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Director/Board Member | 01/12/2005 |
Former positions of Richard Dugan
| Companies | Position | End |
|---|---|---|
Middlebrook Pharmaceuticals, Inc.
 Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Director/Board Member | 03/08/2010 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Director/Board Member | 04/11/2008 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01/09/2002 |
Antisoma, Inc.
 Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceuticals | Director/Board Member | - |
Training of Richard Dugan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Antisoma, Inc.
Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceuticals | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Richard Dugan
